Filing metadata

Accession number
0000950170-23-068922
Form type
Form 4
Filer
SAB Biotherapeutics, Inc.
CIK
CIK 1833214
Filed
Dec 08, 2023
Reporting period
Dec 07, 2023
Description
Insider transaction

Explore SEC Filings Hub